Creating solutions to lower drug spend while building transparent relationships.

Creating solutions to lower drug spend while building transparent relationships.

Learn More

Powering Cost Saving Solutions

  • Formulary Advisement
  • Rebate Administration
  • Medical Rebate Program
  • Specialty Management
  • Data & Analytics

Services we provide

Formulary Management

Health Delegates offers a wide spectrum of formulary management services with the goal of providing clinically effective medications at the lowest net cost.

Learn more
Rebate Administration

Comprehensive rebate program that leverages direct manufacturer contracts and third-party relationships to provide visibility and maximize rebate positions.

Learn more
Medical Rebates

Health Delegates’ Medical Rebate program allows for clients to receive rebates on drugs that flow through the medical benefit.

Learn more
Specialty Pharmacy

Health Delegates’ Specialty Pharmacy Network helps lower net drug cost of specialty medications.

Learn more

Upcoming events

Our pharmaceutical and manufacturer relationships are very important to us. Schedule time with us to learn what we can do to improve the health of your business.

Show Dates Location
sPMCA Business Forum March 5 – 6, 2018 Orlando, FL
AMCP April 23 – 26, 2018 Boston, MA
Assembia Apr 29 – 30 2018 Las Vegas, NV
SIIA September 23 – 26, 2018 Austin, TX
PCMA Annual Meeting September 24 – 25, 2018 Scottsdale, AZ
AMCP October 22 – 25, 2018 Orlando, FL

Latest news

Clinical Update Q3 2018

New Combination Approved for Metastatic Colorectal Cancer On July 12, 2018, the Food and...

Read more
Industry Update Q3 2018

Pfizer Rolls Back Recent Price Hikes Pfizer announced that it would roll back the...

Read more
Clinical Update Q2 2018

New Combination Treatment for HIV-1 Infection Mylan announced that the Food and Drug Administration...

Read more
Industry Update Q2 2018

Top 2018 Patent Expirations In 2018, dozens of branded pharmaceutical products will lose their...

Read more
Industry Update Q1 2018

Analysts Provide Recent Drug Price Increase Details Wells Fargo’s Equity Research Analyst, David Maris,...

Read more
Clinical Update Q1 2018

Generic Sustiva Launched On January 2, 2018, Rising Pharmaceuticals announced the launch of the...

Read more
Clinical Update Q4 2017

Generic Copaxone Approved On Oct. 3, 2017, Mylan received approval from the U.S. Food...

Read more
Industry Update Q4 2017

29% of Healthcare Payments Under Alternative Payment Models A report by the Health Care...

Read more

Let us help you today.

Make an appointment now!

Contact us